Compare · RXO vs SRTA
RXO vs SRTA
Side-by-side comparison of RXO Inc. (RXO) and Strata Critical Medical Inc. (SRTA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RXO and SRTA operate in Transportation Services (Consumer Discretionary), so they compete in similar markets.
- RXO is the larger of the two at $4.83B, about 10.8x SRTA ($445.6M).
- RXO has been more active in the news (6 items in the past 4 weeks vs 2 for SRTA).
- RXO has more recent analyst coverage (25 ratings vs 3 for SRTA).
- Company
- RXO Inc.
- Strata Critical Medical Inc.
- Price
- $29.29+2.86%
- $5.13-2.29%
- Market cap
- $4.83B
- $445.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Transportation Services
- Transportation Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2019
- News (4w)
- 6
- 2
- Recent ratings
- 25
- 3
Latest RXO
- Citizens initiated coverage on RXO, Inc.
- BMO Capital Markets initiated coverage on RXO, Inc. with a new price target
- RXO Partners with Highway to Enhance Freight Security and Streamline Carrier Onboarding
- RXO Schedules Second-Quarter 2026 Earnings and Investor Conference Call for August 6, 2026
- RXO Chairman and CEO Drew Wilkerson Named a Rainmaker by Leading Logistics Publication
- RXO Wins Prestigious “Best in Cargo Security” Award from CargoNet
- RXO to Present at the 16th Annual Wells Fargo Industrials and Materials Conference
- RXO's Latest Curve Report Highlights 16.5% Year-Over-Year Surge in First-Quarter Truckload Spot Rates
- Chief Executive Officer Wilkerson Andrew M. received a gift of 168,943 shares and gifted 168,943 shares, decreasing direct ownership by 96% to 7,775 units (SEC Form 4)
- RXO Provides Brokerage Update, Including Improved Outlook for Truckload Gross Profit Per Load
Latest SRTA
- Amendment: SEC Form SCHEDULE 13G/A filed by Strata Critical Medical Inc.
- Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
- Amendment: Co-CEO and CFO Heyburn William A. covered exercise/tax liability with 31,671 shares, decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) to satisfy tax liability
- Amendment: Co-CEO and General Counsel Tomkiel Melissa M. covered exercise/tax liability with 29,730 shares, decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for tax liability)
- Amendment: Chief Accounting Officer Cohen Amir covered exercise/tax liability with 4,655 shares, decreasing direct ownership by 3% to 146,608 units (SEC Form 4) to satisfy withholding tax
- Amendment: CEO, Logistics Wunsch Scott M covered exercise/tax liability with 5,550 shares, decreasing direct ownership by 0.88% to 625,574 units (SEC Form 4) to satisfy tax liability
- SEC Form SCHEDULE 13G filed by Strata Critical Medical Inc.
- Co-CEO and CFO Heyburn William A. sold $185,909 worth of shares (31,671 units at $5.87), decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) (for withholding tax)
- Co-CEO and General Counsel Tomkiel Melissa M. sold $174,515 worth of shares (29,730 units at $5.87), decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for withholding tax)
- Chief Accounting Officer Cohen Amir sold $27,325 worth of shares (4,655 units at $5.87), decreasing direct ownership by 3% to 146,608 units (SEC Form 4) (tax withholding)